These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 786354)

  • 1. Pharmacokinetic and pharmacological studies with tolamolol in man.
    Faulkner JK; Stopher DA; Walden R
    Br J Clin Pharmacol; 1975 Oct; 2(5):423-8. PubMed ID: 786354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability of tolamolol.
    Faulkner JK; Stopher DA; Walden R; Singleton W; Taylor SH
    Eur J Clin Pharmacol; 1976 Feb; 9(4):315-7. PubMed ID: 989476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker.
    Brown HC; Carruthers SG; Johnston GD; Kelly JG; McAinsh J; McDevitt DG; Shanks RG
    Clin Pharmacol Ther; 1976 Nov; 20(5):524-34. PubMed ID: 10125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of tolamolol and propranolol on exercise heart rate and angina.
    Aronow WS; Spivacek N; Laverty W; Warren M
    Clin Pharmacol Ther; 1975 Apr; 17(4):379-84. PubMed ID: 1173059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of cardioselective beta adrenergic blockade with intravenously administered tolamolol in the treatment of cardiac arrhythmias.
    Amsterdam EA; Lee G; Morrison S; Tonkin MJ; DeMaria AN; Mason DT
    Am J Cardiol; 1976 Aug; 38(2):195-9. PubMed ID: 7952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of a new beta-adrenoceptor blocking compound, tolamolol, on haemo-dynamics and myocardial function in man.
    Hillis WS; Hutton I; Lawrie TD; Lorimer AR; Reid JM
    Br J Pharmacol; 1974 May; 51(1):15-9. PubMed ID: 4155334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of the activity of beta-adrenoceptor antagonists in man.
    Taylor SH; Thadani U; Davidson C; singleton W; Myint S
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):305-6. PubMed ID: 240783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect on plasma prolactin, growth hormone and luteinising hormone concentrations of single oral doses or propranolol and tolamolol in normal man.
    Saxton CA; Faulkner JK; Groom GV
    Eur J Clin Pharmacol; 1981; 21(2):103-8. PubMed ID: 6896183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clearance concept applied to pharmacokinetics: 2. Experience with tolamolol (beta-blocking agent) in renal insufficiency (author's transl)].
    Balant L; Gorgia A; Marmy A; Tschopp JM
    Nephrologie; 1980; 1(4):177-82. PubMed ID: 6895408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-adrenergic blockade of the lung. Dose-dependent cardioselectivity of tolamolol in asthma.
    Fleming GM; Chester EH; Schwartz HJ; Jones PK
    Chest; 1978 Jun; 73(6):807-12. PubMed ID: 350512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined pharmacokinetic and pharmacodynammc studies in man of the adrenergic beta1-receptor antagonist metoprolol.
    Johnsson G; Regårdh CG; Sölvell L
    Acta Pharmacol Toxicol (Copenh); 1975; 36(Suppl 5):31-44. PubMed ID: 1094802
    [No Abstract]   [Full Text] [Related]  

  • 12. Double-blind comparison of tolamolol, propranolol, practolol, and placebo in the treatment of angina pectoris.
    Jackson G; Atkinson L; Oram S
    Br Med J; 1975 Mar; 1(5960):708-12. PubMed ID: 804952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of metabolites in the relationship between pharmacokinetics and the effect of beta blockers. Studies on tolamolol and bufuralol].
    Tschopp JM; Gorgia A; Balant L; Revillard C; Francis RJ; Fabre FJ
    Schweiz Med Wochenschr; 1978 May; 108(20):756-64. PubMed ID: 26114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of tolamolol in the treatment of hypertension.
    Routledge PA; Davies DM; Rawlins MD
    Eur J Clin Pharmacol; 1977 Nov; 12(3):171-4. PubMed ID: 579342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of reduction of exercise heart rate with blood levels of atenolol after oral and intravenous administration.
    Shanks RG; Carruthers SG; Kelly JG; McDevitt DG
    Postgrad Med J; 1977; 53 Suppl 3():70-3. PubMed ID: 928269
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative effects of tolamolol and propranolol on cardiac and peripheral circulatory function in patients with coronary artery disease.
    Miller RR; Vismara LA; Mason DT
    Clin Pharmacol Ther; 1975 Jun; 17(6):713-21. PubMed ID: 1095282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute effects of tolamolol on renal function in hypertensive patients.
    Bianchi C; Bonadio M; Donadio C; Tramonti G; Figus S; Papalexiou P
    Experientia; 1976 Dec; 32(12):1565-6. PubMed ID: 1037307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of the new beta-adrenoceptor blocking agent betaxolol (SL 75212) in man after repeated oral administration.
    Bianchetti G; Blatrix C; Gomeni R; Kilborn JR; Larribaud J; Lücker PW; Thebault JJ; Trocherie S; Morselli PL
    Arzneimittelforschung; 1980; 30(11):1912-6. PubMed ID: 6109538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penbutolol: pharmacokinetics, effect on exercise tachycardia, and in vitro inhibition of radioligand binding.
    Brockmeier D; Hajdù P; Henke W; Mutschler E; Palm D; Rupp W; Spahn H; Verho MT; Wellstein A
    Eur J Clin Pharmacol; 1988; 35(6):613-23. PubMed ID: 2906875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition kinetics and dynamics of nicainoprol, a new antiarrhythmic agent, in humans.
    Ishizaki T; Horai Y; Kubota K; Minegishi A; Echizen H; Chiba K
    Clin Pharmacol Ther; 1987 Nov; 42(5):525-34. PubMed ID: 3677541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.